GL1X · GenesisL1 explorer

Research workbench

Crystal structure of AKT1 in complex with covalent-allosteric AKT inhibitor 15C

Analyse Crystal structure of AKT1 in complex with covalent-allosteric AKT inhibitor 15C in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6S9X
Type
protein
Length
382 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Rac-alpha SERINE/THREONINE-protein kinase
EC
2.7.11.1
UniProt
P31749
Ligands
L1W
Pockets
5 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARac-alpha SERINE/THREONINE-protein kinase (EC 2.7.11.1)protein38231% helix, 24% strandP31749

Ligands and binding sites

  • L1W · ~{N}-[3-[1-[[4-[5-[(4-hydroxyphenyl)methyl]-6-oxidanylidene-2-phenyl-1~{H}-pyrazin-3-yl]phenyl]methyl]piperidin-4-yl]-2-oxidanylidene-1~{H}-benzimidazol-5-yl]propanamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18780.800.8280L1W
22970.550.7636empty
31350.490.7919empty
4640.350.7717empty
5610.330.7513empty

Modifications

Observed in the structure: 1 covalent, 1 disulfide (covalent ligand, disulfide).

Compared structures

  • 6S9X · Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 15c · the same entry in another collection · chain A against A, TM-score 1.00
  • P31749 · AlphaFold monomer V2.0 prediction for rac-alpha SERINE/THREONINE- protein kinase (P31749) · a predicted model of the same protein · chain A against A, TM-score 0.71

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.